HedgePath Pharmaceuticals, Inc. 4
4 · HedgePath Pharmaceuticals, Inc. · Filed Mar 10, 2017
Insider Transaction Report
Form 4
Ono Richard Dana
Director
Transactions
- Exercise/Conversion
Common Stock
2017-03-08+150,000→ 512,400 total - Exercise/Conversion
Common Stock
2017-03-08+300,000→ 300,000 total - Tax Payment
Common Stock
2017-03-08$0.34/sh−118,800$40,392→ 362,400 total - Tax Payment
Common Stock
2017-03-08$0.34/sh−59,400$20,196→ 453,000 total - Exercise/Conversion
Restricted Stock Units
2017-03-08−300,000→ 0 total→ Common Stock (300,000 underlying) - Exercise/Conversion
Common Stock
2017-03-08+300,000→ 481,200 total - Exercise/Conversion
Restricted Stock Units
2017-03-08−300,000→ 0 total→ Common Stock (300,000 underlying) - Tax Payment
Common Stock
2017-03-08$0.34/sh−118,800$40,392→ 181,200 total - Exercise/Conversion
Restricted Stock Units
2017-03-08−150,000→ 0 total→ Common Stock (150,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.
- [F2]The RSUs were issued to the reporting person on July 18, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms.
- [F3]The RSUs were issued to the reporting person on August 14, 2015, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms.
- [F4]The RSUs were issued to the reporting person on July 1, 2016, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms.